Matrix metalloproteinases and endometriosis

Seminars in Reproductive Medicine

Volumn 21, Issue 2, 2003, Pages 155-163

  Osteen, Kevin G ^a   Yeaman, Grant R ^a   Bruner Tran, Kaylon L ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endometriosis; Estrogen; Matrix metalloproteinases; Progesterone; Proinflammatory cytokines

Indexed keywords

MATRIX METALLOPROTEINASE; PROGESTERONE; STEROID;

DISEASE ASSOCIATION; DRUG EXPOSURE; ENDOMETRIOSIS; ENDOMETRIUM; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; GENETIC PREDISPOSITION; HUMAN; IMMUNOPATHOLOGY; MENSTRUAL CYCLE; MENSTRUATION; MENSTRUATION DISORDER; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; RISK FACTOR;

ANIMALS; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MATRIX METALLOPROTEINASES; MENSTRUATION; MULTIGENE FAMILY; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0038042766     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41322     Document Type: Review

References (84)

1. Sampson J. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422-469
2. Liu DT, Hitchcock A. Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology. Br J Obstet Gynaecol 1986;93:859-862
3. TeLinde R, Scott R. Experimental endometriosis. Am J Obstet Gynecol 1950;60:1147-1173
4. Ridley J, Edwards I. Experimental endometriosis in the human. Am J Obstet Gynecol 1958;76:783-790
5. Cramer DW, Wilson E, Stillman RJ, et al. The relation of endometriosis to menstrual characteristics, smoking, and exercise. JAMA 1986;255:1904-1908
6. Cramer DW, Missmer SA. The epidemiology of endometriosis. Ann NY Acad Sci 2002;955:11-22; discussion 34-16, 396-406
7. Dmowski WP, Steele RW, Baker GF. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 1981;141: 377-383
8. Steele RW, Dmowski WP, Marmer DJ. Immunologic aspects of human endometriosis. Am J Reprod Immunol 1984;6:33-36
9. Rier SE, Yeaman GR. Immune aspects of endometriosis: relevance of the uterine mucosal immune system. Semin Reprod Endocrinol 1997;15:209-220
10. Simpson JL, Bischoff FZ. Heritability and molecular genetic studies of endometriosis. Ann NY Acad Sci 2002;955: 239-251; discussion 293-235, 396-406
11. Kennedy S. The genetics of endometriosis. Eur J Obstet Gynecol Reprod Biol 1999;82:129-133
12. Bruner-Tran KL, Rier SE, Eisenberg E, Osteen KG. The potential role of environmental toxins in the pathophysiology of endometriosis. Gynecol Obstet Invest 1999;48(suppl 1):45-56
13. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516
14. Rodgers WH, Osteen KG, Matrisian LM, et al. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 1993;168:253-260
15. Rodgers WH, Matrisian LM, Giudice LC, et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994;94:946-953
16. Osteen KG, Rodgers WH, Gaire M, et al. Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci U S A 1994;91:10129-10133
17. Schatz F, Papp C, Toth-Pal E, Lockwood CJ. Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells. J Clin Endocrinol Metab 1994;78:1467-1472
18. Bruner-Tran K, Eisenberg E, Yeaman G, et al. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab 2002;87:4782-4791
19. Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 1997;99:2851-2857
20. Curry TE Jr, Osteen KG. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 2001;64:1285-1296
21. Osteen KG, Bruner KL, Sharpe-Timms KL. Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Semin Reprod Endocrinol 1996;14: 247-255
22. Gazvani R, Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 2002;123:217-226
23. Schroen DJ, Brinckerhoff CE. Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. Gene Expr 1996;6:197-207
24. Kushner PJ, Agard DA, Greene GL, et al. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 2000;74: 311-317
25. Teyssier C, Belguise K, Galtier F, Chalbos D. Characterization of the physical interaction between estrogen receptor alpha and JUN proteins. J Biol Chem 2001;276:36361-36369
26. Benbow U, Brinckerhoff CE. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 1997;15: 519-526
27. Rudolph-Owen LA, Slayden OD, Matrisian LM, Brenner RM. Matrix metalloproteinase expression in Macaca mulatta endometrium: evidence for zone-specific regulatory tissue gradients. Biol Reprod 1998;59:1349-1359
28. Bamberger AM, Bamberger CM, Gellersen B, Schulte HM. Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proc Natl Acad Sci U S A 1996;93:6169-6174
29. Salmi A, Ammala M, Rutanen EM. Proto-oncogenes c-jun and c-fos are down-regulated in human endometrium during pregnancy: relationship to oestrogen receptor status. Mol Hum Reprod 1996;2:979-984
30. Kirkland JL, Murthy L, Stancel GM. Progesterone inhibits the estrogen-induced expression of c-fos messenger ribonucleic acid in the uterus. Endocrinology 1992;130:3223-3230
31. Osteen KG, Bruner-Tran KL, Ong D, Eisenberg E. Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis. Ann NY Acad Sci 2002;955:139-146; discussion 157-138, 396-406
32. Osteen KG, Keller NR, Feltus FA, Melner MH. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium. Gynecol Obstet Invest 1999; 48(suppl 1):2-13
33. Matrisian LM. Matrix metalloproteinase gene expression. Ann NY Acad Sci 1994;732:42-50
34. Campbell CE, Flenniken AM, Skup D, Williams BR. Identification of a serum- and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene. J Biol Chem 1991;266:7199-7206
35. Edwards DR, Rocheleau H, Sharma RR, et al. Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim Biophys Acta 1992;1171:41-55
36. Logan SK, Garabedian MJ, Campbell CE, Werb Z. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J Biol Chem 1996;271:774-782
37. De Clerck YA, Darville MI, Eeckhout Y, Rousseau GG. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 1994;139:185-191
38. Hammani K, Blakis A, Morsette D, et al. Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene. J Biol Chem 1996;271:25498-25505
39. Wick M, Haronen R, Mumberg D, et al. Structure of the human TIMP-3 gene and its cell cycle-regulated promoter. Biochem J 1995;311(Pt 2):549-554
40. Apte SS, Mattei MG, Olsen BR. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics 1994;19:86-90
41. Riley SC, Leask R, Denison FC, et al. Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition. J Endocrinol 1999;162:351-359
42. Salamonsen LA, Butt AR, Hammond FR, Garcia S, Zhang J. Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 1997;82:1409-1415
43. Bruner KL, Rodgers WH, Gold LI, et al. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 1995;92: 7362-7366
44. Huang HY, Wen Y, Irwin JC, et al. Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor or metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab 1998;83:1721-1729
45. Spuijbroek MD, Dunselman GA, Menheere PP, Evers JL. Early endometriosis invades the extracellular matrix. Fertil Steril 1992;58:929-933
46. Eyster KM, Boles AL, Brannian JD, Hansen KA. DNA microarray analysis of gene expression markers of endometriosis. Fertil Steril 2002;77:38-42
47. Kao LC, Tulac S, Imani B, et al. Expression profile comparisons in eutopic endometrium between women with and without endometriosis during the window of implantation. Fertil Steril 2002;77:S27-S28
48. Zhang J, Salamonsen LA. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation. J Clin Endocrinol Metab 2002;87:2346-2351
49. Vincent AJ, Malakooti N, Zhang J, et al. Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B). Hum Reprod 1999;14:807-815
50. Skinner JL, Riley SC, Gebbie AE, Glasier AF, Critchley HO. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum Reprod 1999;14:793-799
51. Maatta M, Soini Y, Liakka A, Autio-Harmainen H. Localization of MTI-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation. Am J Clin Pathol 2000;114:402-411
52. Zhang J, Salamonsen LA. Tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3 in human endometrium during the menstrual cycle. Mol Hum Reprod 1997;3:735-741
53. Osteen KG. The endocrinology of decidualization. In: Bazer F, ed. The Endocrinology of Pregnancy. Totowa, NJ: Humana Press; 1998:541-663
54. Kamat B, Isaacson P. The immunocytochemical distribution of leukocytic subpopulations in human endometrium. Am J Pathol 1987;127:66-73
55. Bonatz G, Hansmann ML, Buchholz F, et al. Macrophage- and lymphocyte-subtypes in the endometrium during different phases of the ovarian cycle. Int J Gynaecol Obstet 1992; 37:29-36
56. Loke YW, King A. Human Implantation: Cell Biology and Immunology. New York: Cambridge University Press; 1996
57. Yeaman G, Guyre P, Fanger M, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol 1997;61:427-435
58. Vincent AJ, Salamonsen LA. The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives. Hum Reprod 2000; 15(suppl 3):135-143
59. Tabibzadeh S. Signals and molecular pathways involved in apoptosis, with special emphasis on human endometrium. Hum Reprod Update 1995;1:303-323
60. Kokorine I, Marbaix E, Henriet P, et al. Focal cellular origin and regulation of interstitial collagenase (matrix metalloproteinase-1) are related to menstrual breakdown in the human endometrium. J Cell Sci 1996;109(Pt 8):2151-2160
61. Salamonsen LA, Woolley DE. Matrix metalloproteinases in normal menstruation. Hum Reprod 1996;11(suppl 2):124-133
62. Marbaix E, Donnez J, Courtoy PJ, Eeckhout Y. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc Natl Acad Sci U S A 1992;89:11789-11793
63. Nayak NR, Critchley HO, Slayden OD, et al. Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: potential relevance to menstruation. J Clin Endocrinol Metab 2000;85:3442-3452
64. Zhang J, Hampton AL, Nie G, Salamonsen LA. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium. Biol Reprod 2000;62:85-94
65. Singer CF, Marbaix E, Lemoine P, Courtoy PJ, Eeckhout Y. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur J Biochem 1999;259:40-45
66. Keller NR, Sierra-Rivera E, Eisenberg E, Osteen KG. Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1alpha in human endometrial stromal cells. J Clin Endocrinol Metab 2000;85: 1611-1619
67. Osteen KG, Bruner-Tran KL, Keller NR, Eisenberg E. Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis. Ann NY Acad Sci 2002; 955:37-47; discussion 86-88, 396-406
68. Lockwood CJ, Krikun G, Hausknecht VA, Papp C, Schatz F. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal. Endocrinology 1998;139:4607-4613
69. Salamonsen LA, Woolley DE. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol 1999;44:1-27
70. Schatz F, Krikun G, Runic R, et al. Implications of decidualization-associated protease expression in implantation and menstruation. Semin Reprod Endocrinol 1999;17:3-12
71. Koks CA, Dunselman GA, de Goeij AF, Arends JW, Evers JL. Evaluation of a menstrual cup to collect shed endometrium for in vitro studies. Fertil Steril 1997;68:560-564
72. Bruner-Tran KL, Webster-Clair D, Osteen KG. Experimental endometriosis: the nude mouse as a xenographic host. Ann NY Acad Sci 2002;955:328-339; discussion 340-342, 396-406
73. Saito T, Mizumoto H, Kuroki K, et al. [Expression of MMP-3 and TIMP-1 in the endometriosis and the influence of danazol]. Nippon Sanka Fujinka Gakkai Zasshi 1995;47: 495-496
74. Sharpe-Timms KL, Keisler LW, McIntush EW, Keisler DH. Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy. Fertil Steril 1998;69:1128-1134
75. Lessey BA, Metzger DA, Haney AF, McCarty KS Jr. Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril 1989;51:409-415
76. Bergqvist A, Ferno M. Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages. Hum Reprod 1993;8:2211-2217
77. Misao R, Iwagaki S, Fujimoto J, Sun W, Tamaya T. Dominant expression of progesterone receptor form B mRNA in ovarian endometriosis. Horm Res 1999;52:30-34
78. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996;81: 174-179
79. Zeitoun K, Takayama K, Sasano H, et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 1998;83:4474-4480
80. Tseng JF, Ryan IP, Milam TD, et al. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 1996;81:1118-1122
81. Bruner KL, Keller NK, Osteen KG. Interleukin-1α opposes suppression of human endometrial matrix metalloproteinases by progesterone in a model of experimental endometriosis. In: Lemay A, Maheux R, eds. Understanding and Managing Endometriosis: Advances in Research and Practice. New York: Parthenon; 1998:123-130
82. Maas JW, Groothuis PG, Dunselman GA, et al. Development of endometriosis-like lesions after transplantation of human endometrial fragments onto the chick embryo chorioallantoic membrane. Hum Reprod 2001;16:627-631
83. Wenzl RJ, Heinzl H. Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants. Gynecol Obstet Invest 1998;45:253-257
84. Chung HW, Wen Y, Chun SH, et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 2001;75:152-159